| __timestamp | Dynavax Technologies Corporation | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 17763000 | 44820000 |
| Thursday, January 1, 2015 | 22180000 | 82080000 |
| Friday, January 1, 2016 | 37257000 | 97130000 |
| Sunday, January 1, 2017 | 27367000 | 121271000 |
| Monday, January 1, 2018 | 64770000 | 153548000 |
| Tuesday, January 1, 2019 | 74986000 | 202541000 |
| Wednesday, January 1, 2020 | 79256000 | 245164000 |
| Friday, January 1, 2021 | 100156000 | 285773000 |
| Saturday, January 1, 2022 | 131408000 | 325998000 |
| Sunday, January 1, 2023 | 152946000 | 332540000 |
Infusing magic into the data realm
In the competitive landscape of biotechnology, understanding financial trends is crucial. Over the past decade, PTC Therapeutics, Inc. and Dynavax Technologies Corporation have shown significant shifts in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, PTC Therapeutics saw a remarkable increase of over 640% in SG&A expenses, reflecting its aggressive expansion and operational scaling. In contrast, Dynavax Technologies experienced a 760% rise, indicating its strategic investments in marketing and administration.
These trends highlight the differing strategic priorities and growth phases of these biotech firms, offering investors valuable insights into their operational focus.
Who Optimizes SG&A Costs Better? AstraZeneca PLC or Dynavax Technologies Corporation
Breaking Down SG&A Expenses: Pfizer Inc. vs Dynavax Technologies Corporation
SG&A Efficiency Analysis: Comparing Neurocrine Biosciences, Inc. and Dynavax Technologies Corporation
SG&A Efficiency Analysis: Comparing Summit Therapeutics Inc. and Dynavax Technologies Corporation
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs PTC Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Amneal Pharmaceuticals, Inc. and PTC Therapeutics, Inc.
Selling, General, and Administrative Costs: Rhythm Pharmaceuticals, Inc. vs Dynavax Technologies Corporation
PTC Therapeutics, Inc. vs Merus N.V.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for PTC Therapeutics, Inc. and Agios Pharmaceuticals, Inc.
Ligand Pharmaceuticals Incorporated vs Dynavax Technologies Corporation: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Dynavax Technologies Corporation or BioCryst Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Dynavax Technologies Corporation and Novavax, Inc.